Yazar "Sancı, Muzaffer" için Tıp Fakültesi listeleme
-
Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis?
Gülseren, Varol; Kocaer, Mustafa; Özdemir, İsa Aykut; Çakir, İlker; Sancı, Muzaffer; Güngördük, Kemal (Mosby-Elsevier, 2020)Aim: Estrogen receptor (ER), progesterone receptor (PR), and Ki-67 and P53 receptor levels in endometrial curettage material were investigated for their ability to predict lymph node (LN) involvement in patients with ... -
Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre- and postmenopausal periods in endometrioid-type endometrial cancer?
Gülseren, Varol; Kocaer, Mustafa; Güngördük, Özgü Çelikkol; Özdemir, İsa Aykut; Sancı, Muzaffer; Güngördük, Kemal (Galenos Yayincilik, 2018)Objective: We aimed to investigate the correlation of the size and volume of uterine tumors obtained using positron emission tomography/computed tomography (PET/CT) and pathology specimens in patients with endometrioid-type ... -
MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer
Sancı, Muzaffer; Güngördük, Kemal; Gülseren, Varol; Karadeniz, Tuğba; Kocaer, Mustafa; Güngördük, Özgü; Özdemir, İsa A. (Lippincott Williams & Wilkins, 2018)The aim of this study was to examine the associations between microcystic, elongated, and fragmented (MELF) pattern and other prognostic factors and lymph node involvement, disease-free survival, and overall survival (OS) ... -
A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer
Aşıcıoğlu, Osman; Güngördük, Kemal; Özdemir, Aykut; Güngördük, Özgü; Gökcü, Mehmet; Yaşar, Levent; Sancı, Muzaffer (Taylor & Francis Inc, 2019)The purpose of this study was to develop a model predicting the probability of pelvic-paraaortic node metastases in high-risk endometrial cancer patients. This trial included 41 high-risk endometrial cancer patients. All ...